Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.
Source | Last Updated |
---|---|
Alliance of Genome Resources | October 9, 2024 |
Disease ID | Disease Name | Alliance of Genome Resources ID ▲ | Species | Gene ID | Gene Symbol | FlyGlycoDB | Evidence Code Names | References |
---|---|---|---|---|---|---|---|---|
DOID:0050588 | muscular dystrophy-dystroglycanopathy type B1 | WB:WBGene00010694 | Caenorhabditis elegans | 3565692 | bgnt-1.5 |
|
||
DOID:0050741 | alcohol dependence | WB:WBGene00010701 | Caenorhabditis elegans | 181648 | ent-2 |
|
||
DOID:0111278 | histiocytosis-lymphadenopathy plus syndrome | WB:WBGene00010701 | Caenorhabditis elegans | 181648 | ent-2 |
|
||
DOID:2316 | brain ischemia | WB:WBGene00010701 | Caenorhabditis elegans | 181648 | ent-2 |
|
||
DOID:6652 | diffuse idiopathic skeletal hyperostosis | WB:WBGene00010701 | Caenorhabditis elegans | 181648 | ent-2 |
|
||
DOID:0110637 | muscular dystrophy-dystroglycanopathy type B6 | WB:WBGene00010716 | Caenorhabditis elegans | 187206 | lge-1 |
|
||
DOID:0111242 | congenital muscular dystrophy-dystroglycanopathy type A6 | WB:WBGene00010716 | Caenorhabditis elegans | 187206 | lge-1 |
|
||
DOID:11727 | facioscapulohumeral muscular dystrophy | WB:WBGene00010716 | Caenorhabditis elegans | 187206 | lge-1 |
|
||
DOID:0050588 | muscular dystrophy-dystroglycanopathy type B1 | WB:WBGene00010716 | Caenorhabditis elegans | 187206 | lge-1 |
|
||
DOID:0080556 | congenital disorder of glycosylation Id | WB:WBGene00010720 | Caenorhabditis elegans | 175065 | algn-3 |
|
||
DOID:5212 | congenital disorder of glycosylation | WB:WBGene00010720 | Caenorhabditis elegans | 175065 | algn-3 |
|
||
DOID:12801 | mucopolysaccharidosis III | WB:WBGene00010722 | Caenorhabditis elegans | 175063 | K09E4.4 |
|
||
DOID:12798 | mucopolysaccharidosis | WB:WBGene00010722 | Caenorhabditis elegans | 175063 | K09E4.4 |
|
||
DOID:0110178 | Charcot-Marie-Tooth disease axonal type 2V | WB:WBGene00010722 | Caenorhabditis elegans | 175063 | K09E4.4 |
|
||
DOID:10754 | otitis media | WB:WBGene00010722 | Caenorhabditis elegans | 175063 | K09E4.4 |
|
||
DOID:0111394 | mucopolysaccharidosis type IIIB | WB:WBGene00010722 | Caenorhabditis elegans | 175063 | K09E4.4 |
|
||
DOID:1289 | neurodegenerative disease | WB:WBGene00010755 | Caenorhabditis elegans | 176441 | vglu-2 |
|
||
DOID:11446 | sciatic neuropathy | WB:WBGene00010755 | Caenorhabditis elegans | 176441 | vglu-2 |
|
||
DOID:0110555 | autosomal dominant nonsyndromic deafness 25 | WB:WBGene00010755 | Caenorhabditis elegans | 176441 | vglu-2 |
|
||
DOID:14330 | Parkinson's disease | WB:WBGene00010755 | Caenorhabditis elegans | 176441 | vglu-2 |
|
||
DOID:224 | transient cerebral ischemia | WB:WBGene00010755 | Caenorhabditis elegans | 176441 | vglu-2 |
|
||
DOID:14250 | Down syndrome | WB:WBGene00010757 | Caenorhabditis elegans | 259529 | pad-2 |
|
||
DOID:0111527 | spinal muscular atrophy with progressive myoclonic epilepsy | WB:WBGene00010769 | Caenorhabditis elegans | 173120 | asah-1 |
|
||
DOID:1927 | sphingolipidosis | WB:WBGene00010769 | Caenorhabditis elegans | 173120 | asah-1 |
|
||
DOID:0050464 | Farber lipogranulomatosis | WB:WBGene00010769 | Caenorhabditis elegans | 173120 | asah-1 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024